Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

74.06 +0.15 (+0.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
11 Analysts Have This To Say About Hologic
 
Via Benzinga
3 Reasons to Sell HOLX and 1 Stock to Buy Instead
Over the past six months, Hologic’s stock price fell to $65.75. Shareholders have lost 17.6% of their capital, which is disappointing considering the S&P 500 has climbed by 6.4%. This was partly driven... 
Via StockStory
Topics Stocks
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference
From Hologic, Inc.
Via Business Wire
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
From Hologic, Inc.
Via Business Wire
Hologic Q1 Earnings Assessment
 
Via Benzinga
Hologic Earnings Report: Q1 Overview
 
Via Benzinga
Hologic Earnings Review: Q1 Summary
 
Via Benzinga
GE HealthCare Earnings: What To Look For From GEHC
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
NASDAQ:HOLX is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Uncover the potential of HOLOGIC INC, an undervalued stock. NASDAQ:HOLX maintains a strong financial position and offers an appealing valuation. 
Via Chartmill
QuidelOrtho Earnings: What To Look For From QDEL
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be announcing earnings results tomorrow afternoon. Here’s what to expect. 
Via StockStory
Which S&P500 stocks are moving on Thursday?
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Gapping S&P500 stocks in Thursday's session
Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
Earnings Scheduled For February 5, 2025
 
Via Benzinga
5 Analysts Have This To Say About Hologic
 
Via Benzinga
How Is The Market Feeling About Hologic?
 
Via Benzinga
Wondering what's happening in today's S&P500 pre-market session?
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Uber To $80? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
Hologic (NASDAQ:HOLX) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Misses Expectations
Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue... 
Via StockStory
Peering Into Hologic's Recent Short Interest
 
Via Benzinga
Hologic Announces Financial Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Friday's pre-market session: top gainers and losers in the S&P500 index
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session. 
Via Chartmill
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments. 
Via Benzinga
Topics Artificial Intelligence Government Stocks
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
From Hologic, Inc.
Via Business Wire
FDA Warns Hologic Over BioZorb Manufacturing Violations
FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted 
Via Benzinga
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
From Hologic, Inc.
Via Business Wire
Hologic Completes Acquisition of Gynesonics, Inc.
From Hologic, Inc.
Via Business Wire
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
From Hologic, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.